Neu5Gc-mediated high-affinity interaction is dispensable for CD22 cis-ligands to regulate B cell signaling

Area of Science:

• Immunology
• Glycobiology
• Cell Signaling

Background:

• CD22 (Siglec-2) is an inhibitory B cell receptor recognizing α2,6 sialic acids.
• CD22 interacts with both cis- and trans-ligands, regulating BCR and tonic signaling.
• Mouse CD22 exhibits high affinity for Neu5Gc, while human CD22 binds distinct high-affinity ligands.

Purpose of the Study:

• To investigate how high- versus low-affinity CD22 ligands regulate B cell signaling.
• To understand the role of CD22 ligand affinity in B cell function.

Main Methods:

• Utilized Cmah^-/- mice deficient in Neu5Gc and wild-type B cells.
• Analyzed B cell signaling pathways, including BCR ligation-induced and tonic signaling.
• Phenotypic analysis of B cells lacking Neu5Gc.

Main Results:

• CD22 interaction with endogenous ligands enhanced BCR signaling and reduced tonic signaling in both wild-type and Cmah^-/- B cells.
• Cmah^-/- B cells showed no alterations in phenotypes associated with tonic signaling.
• Low-affinity CD22 cis-ligand interaction is sufficient for regulating B cell signaling.

Conclusions:

• Low-affinity CD22 cis-ligand interactions are sufficient for modulating B cell signaling.
• High-affinity CD22 ligands may regulate B cells by competing with exogenous trans-ligands for CD22 binding.